Recent meetings
| Date | Commissioner / Cabinet | Topic | File |
|---|---|---|---|
| 29 Nov 2017 | Vytenis Andriukaitis Commissioner | Pharmaceutical incentives, antimicrobial resistance | — |
| 29 Nov 2017 | Vytenis Andriukaitis Commissioner | Pharmaceutical incentives, antimicrobial resistance | SRC |
Mission & Goals
Ipsen is a global biopharmaceutical company with a focus on bringing transformative medicines to patients in three therapeutic areas: Oncology, Rare Disease and Neuroscience. Our pipeline is fueled by external innovation and supported by nearly 100 years of development experience and global hubs in the U.S., France and the U.K. Our teams in more than 40 countries and our partnerships around the world enable us to bring medicines to patients in more than 80 countries.
EU Legislative Interests
General Pharmaceutical Legislation Critical Medicines Act Biotech Act HTA Regulation Clinical Trials Directive Urban Wastewater Treatment Directive
Interests Represented
Promotes their own interests or the collective interests of their members
Member Of
Ipsen Pharma is a member of several organisations that may engage in activities covered by the Register: - EFPIA - EuropaBio - EUCOPE
Organisation Members
N/A